AJCC eighth edition staging for cutaneous SCC

The resulting stage gives the care team a shared description of the cancer's anatomical extent. It supports treatment planning, but it does not capture every feature of a person's health or tumour biology.

The tumour category considers more than surface width. Depth of invasion, involvement of a named nerve, and growth into nearby structures can raise the category. The node category describes whether regional lymph nodes contain cancer and may include their size, number, side, and extension beyond a node. The metastasis category records distant spread.

AJCC eighth edition cutaneous SCC staging has specific anatomical eligibility, including cancers arising on the head and neck. A skin cancer in another location may be described with a different staging framework. The pathology report and tumour site therefore need to be interpreted together.

Ask whether your stage is clinical, based on examination and scans, or pathological, incorporating tissue removed during surgery. Confirm the primary skin site and which staging framework was used. If lymph nodes feel abnormal or the tumour has concerning local features, the team may arrange imaging or targeted node assessment.

Treatment may involve complete surgical removal, radiotherapy, systemic therapy, or a combination, depending on resectability, nodal involvement, previous treatment, and general health. A stage label should be read alongside the pathology details and the multidisciplinary team's recommendation.

Arrange a clinical review for a treated area that develops a new lump, persistent ulceration, bleeding, increasing pain, numbness, or weakness. A growing or firm lump near the jaw, neck, ear, or other regional node area also deserves prompt assessment.

Seek urgent care if swelling affects breathing or swallowing, or if new weakness develops rapidly. Urgency comes from the effect of these symptoms, not from an assumption about their cause.

Useful questions include: Which tumour, node, and metastasis categories apply? Does the report mention deep invasion, nerve involvement, bone involvement, or extension beyond a lymph node? Would another scan or pathology review change the treatment recommendation?